Skip to content

Clinical trials

Leukemia, Myelomonocytic, Chronic trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Country / region: Czechia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20161
20172
20181
20202
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status2
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Astex Pharmaceuticals, Inc.2
Novartis Pharmaceuticals2
Millennium Pharmaceuticals, Inc.1
Pfizer1
Taiho Oncology, Inc.1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic11
Myelodysplastic Syndromes10
Leukemia, Myeloid, Acute6
Anemia, Refractory, with Excess of Blasts3
Leukemia3
Anemia, Refractory2
Blast Crisis1
Breast Neoplasms1
Burkitt Lymphoma1
Carcinoma, Embryonal1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.